Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 14, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012969.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protocadherin-1-like, transcript variant X3
COORDINATES: polyA evidence [ECO:0006239]
protocadherin-1-like, transcript variant X2
protocadherin-1-like, transcript variant X1
protocadherin-1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
uncharacterized LOC122556875, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122556875, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122556418, transcript variant X2
uncharacterized LOC122556418, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein diaphanous homolog 1-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
protocadherin beta-15-like, transcript variant X9
protocadherin beta-15-like, transcript variant X7
protocadherin beta-15-like, transcript variant X6
protocadherin beta-15-like, transcript variant X5
protocadherin beta-15-like, transcript variant X2
protocadherin beta-15-like, transcript variant X3
protocadherin beta-15-like, transcript variant X4
protocadherin beta-15-like, transcript variant X8
protocadherin beta-15-like, transcript variant X13
protocadherin beta-15-like, transcript variant X11
protocadherin beta-15-like, transcript variant X10
protocadherin beta-15-like, transcript variant X14
protocadherin beta-15-like, transcript variant X15
protocadherin beta-15-like, transcript variant X1
protocadherin beta-15-like, transcript variant X12
protocadherin beta-15-like, transcript variant X17
protocadherin beta-15-like, transcript variant X16
protocadherin gamma-A11-like isoform X17
protocadherin gamma-A11-like isoform X13
protocadherin gamma-A10-like isoform X11
protocadherin gamma-A11-like isoform X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 10% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 28% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protocadherin gamma-A10-like
protocadherin-10-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 135 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protocadherin-10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 135 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protocadherin-10-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protocadherin-10-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protocadherin-10-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
protocadherin-10-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protocadherin-10-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protocadherin-10-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122556426, transcript variant X1
uncharacterized LOC122556426, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
fat-like cadherin-related tumor suppressor homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 4% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 204 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 108 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 108 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dead end protein homolog 1-like, transcript variant X1
dead end protein homolog 1-like, transcript variant X2
dead end protein homolog 1-like, transcript variant X3
dead end protein homolog 1-like isoform X1
dead end protein homolog 1-like isoform X2
histidyl-tRNA synthetase, transcript variant X2
histidyl-tRNA synthetase, transcript variant X1
CRAL-TRIO domain-containing protein C3H8.02-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
CRAL-TRIO domain-containing protein C3H8.02-like, transcript variant X3
CRAL-TRIO domain-containing protein C3H8.02-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
CRAL-TRIO domain-containing protein C3H8.02-like isoform X1
CRAL-TRIO domain-containing protein C3H8.02-like isoform X3
CRAL-TRIO domain-containing protein C3H8.02-like isoform X2
UDP-glucose 6-dehydrogenase-like, transcript variant X3
UDP-glucose 6-dehydrogenase-like, transcript variant X1
UDP-glucose 6-dehydrogenase-like, transcript variant X2
transmembrane and coiled-coil domains 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transmembrane and coiled-coil domains 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane and coiled-coil domain-containing protein 6 isoform X3
transmembrane and coiled-coil domain-containing protein 6 isoform X1
NADH:ubiquinone oxidoreductase subunit A2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
NADH:ubiquinone oxidoreductase subunit A2, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2
transmembrane and coiled-coil domains 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane and coiled-coil domain-containing protein 6 isoform X2
kinesin-like protein CIN8, transcript variant X1
kinesin-like protein CIN8, transcript variant X2
kinesin-like protein CIN8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
probable UDP-sugar transporter protein SLC35A4
SLC35A4 upstream open reading frame protein
amyloid beta (A4) precursor protein-binding, family B, member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
amyloid beta (A4) precursor protein-binding, family B, member 3, transcript variant X1
amyloid beta (A4) precursor protein-binding, family B, member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
amyloid-beta A4 precursor protein-binding family B member 3 isoform X1
amyloid-beta A4 precursor protein-binding family B member 3 isoform X3
amyloid-beta A4 precursor protein-binding family B member 3 isoform X2
39S ribosomal protein L22, mitochondrial
gem (nuclear organelle) associated protein 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X4
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X6
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X5
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1b
COORDINATES: nucleotide motif:Rfam:12.0:RF00092
CD74 molecule, major histocompatibility complex, class II invariant chain b, transcript variant X1
CD74 molecule, major histocompatibility complex, class II invariant chain b, transcript variant X2
CD74 molecule, major histocompatibility complex, class II invariant chain b, transcript variant X3
CD74 molecule, major histocompatibility complex, class II invariant chain b, transcript variant X4
CD74 molecule, major histocompatibility complex, class II invariant chain b isoform X1
CD74 molecule, major histocompatibility complex, class II invariant chain b isoform X2
CD74 molecule, major histocompatibility complex, class II invariant chain b isoform X3
CD74 molecule, major histocompatibility complex, class II invariant chain b isoform X4
calcium/calmodulin-dependent protein kinase type II subunit alpha-like
caudal type homeobox 1 b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
caudal type homeobox 1 b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
platelet-derived growth factor receptor, beta polypeptide, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
platelet-derived growth factor receptor, beta polypeptide, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
platelet-derived growth factor receptor beta isoform X1
platelet-derived growth factor receptor beta isoform X2
DAP3 binding cell death enhancer 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
DAP3 binding cell death enhancer 1, transcript variant X1
transmembrane O-methyltransferase homolog, transcript variant X1
transmembrane O-methyltransferase homolog, transcript variant X2
transmembrane O-methyltransferase homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
family with sequence similarity 50 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
mastermind-like transcriptional coactivator 1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B-like
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B-like isoform X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B-like isoform X2
uncharacterized LOC122556466, transcript variant X1
uncharacterized protein LOC122556466 isoform X1
uncharacterized LOC122556466, transcript variant X2
uncharacterized protein LOC122556466 isoform X2
TBC1 domain family member 9B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
TBC1 domain family member 9B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
fms related receptor tyrosine kinase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
fms related receptor tyrosine kinase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
vascular endothelial growth factor receptor 3 isoform X2
vascular endothelial growth factor receptor 3 isoform X1
zinc-binding protein A33-like, transcript variant X1
zinc-binding protein A33-like, transcript variant X2
zinc-binding protein A33-like isoform X1
zinc-binding protein A33-like isoform X2
zinc finger HIT domain-containing protein 2
mast/stem cell growth factor receptor Kit-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RELT-like protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RELT-like protein 2, transcript variant X2
F-BAR and double SH3 domains protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
F-BAR and double SH3 domains protein 2-like isoform X1
F-BAR and double SH3 domains protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
F-BAR and double SH3 domains protein 2-like isoform X2
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
mediator complex subunit 7, transcript variant X1
mediator complex subunit 7, transcript variant X2
mediator of RNA polymerase II transcription subunit 7
cytoplasmic FMR1 interacting protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cytoplasmic FMR1 interacting protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cytoplasmic FMR1 interacting protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cytoplasmic FMR1 interacting protein 2, transcript variant X3
cytoplasmic FMR1 interacting protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cytoplasmic FMR1 interacting protein 2, transcript variant X4
cytoplasmic FMR1 interacting protein 2, transcript variant X6
cytoplasmic FMR1-interacting protein 2 isoform X1
cytoplasmic FMR1-interacting protein 2 isoform X2
hyaluronan-mediated motility receptor (RHAMM), transcript variant X1
hyaluronan-mediated motility receptor (RHAMM), transcript variant X2
hyaluronan mediated motility receptor isoform X1
hyaluronan mediated motility receptor isoform X2
methionine adenosyltransferase II, beta, transcript variant X2
methionine adenosyltransferase 2 subunit beta isoform X2
methionine adenosyltransferase II, beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
methionine adenosyltransferase II, beta, transcript variant X1
methionine adenosyltransferase 2 subunit beta isoform X1
methionine adenosyltransferase 2 subunit beta isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glutamate receptor, ionotropic, AMPA 1a, transcript variant X2
glutamate receptor, ionotropic, AMPA 1a, transcript variant X4
glutamate receptor, ionotropic, AMPA 1a, transcript variant X1
glutamate receptor, ionotropic, AMPA 1a, transcript variant X3
glutamate receptor, ionotropic, AMPA 1a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate receptor, ionotropic, AMPA 1a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LON peptidase N-terminal domain and RING finger protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
LON peptidase N-terminal domain and RING finger protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
LON peptidase N-terminal domain and RING finger protein 2-like isoform X1
LON peptidase N-terminal domain and RING finger protein 2-like isoform X2
fatty acid hydroxylase domain containing 2, transcript variant X2
fatty acid hydroxylase domain containing 2, transcript variant X3
fatty acid hydroxylase domain containing 2, transcript variant X1
fatty acid hydroxylase domain-containing protein 2 isoform X1
fatty acid hydroxylase domain-containing protein 2 isoform X2
La ribonucleoprotein 1, translational regulator
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X4
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like isoform X1
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like isoform X3
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like
heart- and neural crest derivatives-expressed protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 61% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122556491, transcript variant X2
uncharacterized LOC122556491, transcript variant X3
uncharacterized LOC122556491, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC122556491 isoform X3
uncharacterized protein LOC122556491 isoform X1
uncharacterized protein LOC122556491 isoform X2
prolyl 4-hydroxylase subunit alpha-2-like, transcript variant X3
prolyl 4-hydroxylase subunit alpha-2-like, transcript variant X5
prolyl 4-hydroxylase subunit alpha-2-like, transcript variant X1
prolyl 4-hydroxylase subunit alpha-2-like, transcript variant X6
prolyl 4-hydroxylase subunit alpha-2-like, transcript variant X4
prolyl 4-hydroxylase subunit alpha-2-like, transcript variant X2
prolyl 4-hydroxylase subunit alpha-2-like isoform X2
prolyl 4-hydroxylase subunit alpha-2-like isoform X4
prolyl 4-hydroxylase subunit alpha-2-like isoform X1
prolyl 4-hydroxylase subunit alpha-2-like isoform X5
prolyl 4-hydroxylase subunit alpha-2-like isoform X3
exocyst complex component 1-like, transcript variant X3
exocyst complex component 1-like, transcript variant X1
exocyst complex component 1-like, transcript variant X2
exocyst complex component 1-like isoform X2
exocyst complex component 1-like isoform X1
exocyst complex component 1-like isoform X3
RAD50 homolog, double strand break repair protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RAD50 homolog, double strand break repair protein, transcript variant X5
RAD50 homolog, double strand break repair protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RAD50 homolog, double strand break repair protein, transcript variant X1
RAD50 homolog, double strand break repair protein, transcript variant X6
RAD50 homolog, double strand break repair protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
interleukin-4-like, transcript variant X1
interleukin-4-like, transcript variant X2
uncharacterized protein LOC122556891 isoform X2
kinesin family member 3A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
kinesin family member 3A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
kinesin family member 3A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
POU domain, class 4, transcription factor 3
RNA binding motif protein 27, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
RNA binding motif protein 27, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RNA binding motif protein 27, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
sprouty homolog 4 (Drosophila), transcript variant X2
sprouty homolog 4 (Drosophila), transcript variant X4
sprouty homolog 4 (Drosophila), transcript variant X1
sprouty homolog 4 (Drosophila), transcript variant X3
fibroblast growth factor 1-like, transcript variant X4
fibroblast growth factor 1-like, transcript variant X1
fibroblast growth factor 1-like, transcript variant X2
fibroblast growth factor 1-like, transcript variant X3
fibroblast growth factor 1-like, transcript variant X5
fibroblast growth factor 1-like isoform X1
fibroblast growth factor 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
platelet-derived growth factor receptor-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
coiled-coil domain-containing protein 69-like
solute carrier family 36 member 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 36 member 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
solute carrier family 36 member 1, transcript variant X2
solute carrier family 36 member 1, transcript variant X1
solute carrier family 36 member 1, transcript variant X5
solute carrier family 36 member 1, transcript variant X6
solute carrier family 36 member 1, transcript variant X4
solute carrier family 36 member 1, transcript variant X3
proton-coupled amino acid transporter 1 isoform X1
proton-coupled amino acid transporter 1 isoform X2
proton-coupled amino acid transporter 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
protocadherin Fat 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protocadherin Fat 1-like, transcript variant X1
protocadherin Fat 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
secreted protein, acidic, cysteine-rich (osteonectin)
translation initiation factor IF-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
translation initiation factor IF-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
translation initiation factor IF-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
GTPase activating protein (SH3 domain) binding protein 1, transcript variant X1
GTPase activating protein (SH3 domain) binding protein 1, transcript variant X3
GTPase activating protein (SH3 domain) binding protein 1, transcript variant X4
GTPase activating protein (SH3 domain) binding protein 1, transcript variant X2
ras GTPase-activating protein-binding protein 1
glycine receptor, alpha 1, transcript variant X3
glycine receptor, alpha 1, transcript variant X1
glycine receptor, alpha 1, transcript variant X4
glycine receptor subunit alphaZ1 isoform X3
glycine receptor subunit alphaZ1 isoform X1
glycine receptor subunit alphaZ1 isoform X4
glycine receptor, alpha 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glycine receptor subunit alphaZ1 isoform X2
glutaredoxin domain-containing cysteine-rich protein 2
E3 ubiquitin-protein ligase SH3RF2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase SH3RF2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase SH3RF2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
E3 ubiquitin-protein ligase SH3RF2-like, transcript variant X3
E3 ubiquitin-protein ligase SH3RF2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase SH3RF1-like isoform X4
E3 ubiquitin-protein ligase SH3RF2-like isoform X3
E3 ubiquitin-protein ligase SH3RF2-like isoform X1
E3 ubiquitin-protein ligase SH3RF2-like isoform X2
NudC domain containing 2, transcript variant X2
NudC domain containing 2, transcript variant X1
steroid receptor RNA activator 1, transcript variant X1
steroid receptor RNA activator 1 isoform X1
steroid receptor RNA activator 1, transcript variant X2
steroid receptor RNA activator 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
HMG box domain containing 3, transcript variant X1
HMG box domain containing 3, transcript variant X9
HMG box domain containing 3, transcript variant X8
HMG box domain containing 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
HMG box domain containing 3, transcript variant X2
HMG box domain containing 3, transcript variant X7
HMG box domain containing 3, transcript variant X5
HMG box domain containing 3, transcript variant X3
HMG box domain containing 3, transcript variant X6
HMG box domain containing 3, transcript variant X4
HMG domain-containing protein 3 isoform X1
HMG domain-containing protein 3 isoform X3
HMG domain-containing protein 3 isoform X2
HMG domain-containing protein 3 isoform X4
vascular endothelial growth factor C-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
vascular endothelial growth factor C-like isoform X4
vascular endothelial growth factor C-like, transcript variant X3
vascular endothelial growth factor C-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
vascular endothelial growth factor C-like, transcript variant X1
vascular endothelial growth factor C-like isoform X3
vascular endothelial growth factor C-like isoform X2
vascular endothelial growth factor C-like isoform X1
arginyl-tRNA synthetase 1, transcript variant X4
arginyl-tRNA synthetase 1, transcript variant X3
arginyl-tRNA synthetase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
arginyl-tRNA synthetase 1, transcript variant X1
arginine--tRNA ligase, cytoplasmic isoform X1
arginine--tRNA ligase, cytoplasmic isoform X2
arginyl-tRNA synthetase 1, transcript variant X5
arginine--tRNA ligase, cytoplasmic isoform X3
rho GTPase-activating protein 7-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rho GTPase-activating protein 7-like, transcript variant X3
rho GTPase-activating protein 7-like, transcript variant X5
rho GTPase-activating protein 7-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
rho GTPase-activating protein 7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
rho GTPase-activating protein 7-like isoform X1
rho GTPase-activating protein 7-like isoform X2
rho GTPase-activating protein 7-like isoform X3
sarcoglycan, delta (dystrophin-associated glycoprotein), transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sarcoglycan, delta (dystrophin-associated glycoprotein), transcript variant X4
sarcoglycan, delta (dystrophin-associated glycoprotein), transcript variant X1
sarcoglycan, delta (dystrophin-associated glycoprotein), transcript variant X5
sarcoglycan, delta (dystrophin-associated glycoprotein), transcript variant X3
sarcoglycan, delta (dystrophin-associated glycoprotein), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins
zinc finger CCHC domain-containing protein 10
AF4/FMR2 family, member 4, transcript variant X2
AF4/FMR2 family, member 4, transcript variant X3
AF4/FMR2 family, member 4, transcript variant X1
AF4/FMR2 family, member 4, transcript variant X4
AF4/FMR2 family, member 4, transcript variant X5
uncharacterized LOC122556545, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122556545, transcript variant X1
uncharacterized LOC122556545, transcript variant X2
liver-expressed antimicrobial peptide 2-like
cytochrome b-c1 complex subunit 8, transcript variant X3
cytochrome b-c1 complex subunit 8, transcript variant X1
cytochrome b-c1 complex subunit 8, transcript variant X4
cytochrome b-c1 complex subunit 8, transcript variant X2
protein Shroom3-like, transcript variant X2
protein Shroom3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein Shroom3-like, transcript variant X3
sosondowah ankyrin repeat domain family member Ab
ankyrin repeat domain-containing protein SOWAHA
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ring finger protein 14, transcript variant X4
ring finger protein 14, transcript variant X2
ring finger protein 14, transcript variant X1
E3 ubiquitin-protein ligase RNF14 isoform X1
E3 ubiquitin-protein ligase RNF14 isoform X3
ring finger protein 14, transcript variant X3
E3 ubiquitin-protein ligase RNF14 isoform X2
signal recognition particle 9 kDa protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122556898, transcript variant X5
uncharacterized LOC122556898, transcript variant X1
uncharacterized LOC122556898, transcript variant X4
uncharacterized LOC122556898, transcript variant X3
uncharacterized LOC122556898, transcript variant X2
gamma-aminobutyric acid receptor subunit gamma-2-like, transcript variant X4
gamma-aminobutyric acid receptor subunit gamma-2-like, transcript variant X3
gamma-aminobutyric acid receptor subunit gamma-2-like, transcript variant X1
gamma-aminobutyric acid receptor subunit gamma-2-like, transcript variant X2
gamma-aminobutyric acid receptor subunit gamma-2-like isoform X2
gamma-aminobutyric acid receptor subunit gamma-2-like isoform X1
gamma-aminobutyric acid receptor subunit alpha-1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-1-like, transcript variant X2
gamma-aminobutyric acid receptor subunit alpha-1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-1-like isoform X1
gamma-aminobutyric acid receptor subunit alpha-1-like isoform X2
gamma-aminobutyric acid receptor subunit alpha-6-like, transcript variant X3
gamma-aminobutyric acid receptor subunit alpha-6-like, transcript variant X2
gamma-aminobutyric acid receptor subunit alpha-6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-6-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-6-like isoform X3
gamma-aminobutyric acid receptor subunit alpha-6-like isoform X2
gamma-aminobutyric acid receptor subunit alpha-6-like isoform X4
gamma-aminobutyric acid receptor subunit alpha-6-like isoform X1
gamma-aminobutyric acid receptor subunit alpha-6-like, transcript variant X5
gamma-aminobutyric acid receptor subunit alpha-6-like isoform X5
uncharacterized LOC122556559, transcript variant X1
uncharacterized LOC122556559, transcript variant X2
gamma-aminobutyric acid type A receptor subunit beta2a
gamma-aminobutyric acid receptor subunit beta-2a
ATPase phospholipid transporting 10B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATPase phospholipid transporting 10B, transcript variant X5
ATPase phospholipid transporting 10B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ATPase phospholipid transporting 10B, transcript variant X6
ATPase phospholipid transporting 10B, transcript variant X7
ATPase phospholipid transporting 10B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ATPase phospholipid transporting 10B, transcript variant X3
phospholipid-transporting ATPase VB isoform X1
phospholipid-transporting ATPase VB isoform X2
phospholipid-transporting ATPase VB isoform X3
phospholipid-transporting ATPase VB isoform X4
sorbin and SH3 domain-containing protein 2-like, transcript variant X1
sorbin and SH3 domain-containing protein 2-like, transcript variant X4
sorbin and SH3 domain-containing protein 2-like, transcript variant X3
sorbin and SH3 domain-containing protein 2-like, transcript variant X7
sorbin and SH3 domain-containing protein 2-like, transcript variant X2
sorbin and SH3 domain-containing protein 2-like, transcript variant X6
sorbin and SH3 domain-containing protein 2-like isoform X6
sorbin and SH3 domain-containing protein 1-like isoform X5
sorbin and SH3 domain-containing protein 2-like, transcript variant X5
sorbin and SH3 domain-containing protein 2-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
solute carrier family 22 member 5-like, transcript variant X1
solute carrier family 22 member 5-like, transcript variant X2
uncharacterized LOC122556569, transcript variant X2
uncharacterized LOC122556569, transcript variant X4
uncharacterized LOC122556569, transcript variant X3
uncharacterized LOC122556569, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 22 member 5-like isoform X2
solute carrier family 22 member 5-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 22 member 5-like, transcript variant X6
solute carrier family 22 member 5-like, transcript variant X4
solute carrier family 22 member 5-like, transcript variant X3
solute carrier family 22 member 5-like, transcript variant X5
solute carrier family 22 member 5-like, transcript variant X7
solute carrier family 22 member 5-like, transcript variant X8
solute carrier family 22 member 5-like isoform X3
similar to RNA sequence, mRNA (same species):INSD:HM044308.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 997 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 910 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC122556573, transcript variant X2
uncharacterized LOC122556573, transcript variant X1
uncharacterized LOC122556573, transcript variant X4
uncharacterized LOC122556573, transcript variant X3
long-chain-fatty-acid--CoA ligase 6-like, transcript variant X2
long-chain-fatty-acid--CoA ligase 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
long-chain-fatty-acid--CoA ligase 6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
long-chain-fatty-acid--CoA ligase 6-like isoform X2
long-chain-fatty-acid--CoA ligase 6-like isoform X1
long-chain-fatty-acid--CoA ligase 6-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
long-chain-fatty-acid--CoA ligase 6-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
long-chain-fatty-acid--CoA ligase 6-like, transcript variant X6
long-chain-fatty-acid--CoA ligase 6-like isoform X3
uncharacterized LOC122556575, transcript variant X6
uncharacterized LOC122556575, transcript variant X7
uncharacterized LOC122556575, transcript variant X5
uncharacterized LOC122556575, transcript variant X3
uncharacterized LOC122556575, transcript variant X1
uncharacterized LOC122556575, transcript variant X4
uncharacterized LOC122556575, transcript variant X2
uncharacterized LOC122556575, transcript variant X11
uncharacterized protein LOC122556575 isoform X5
uncharacterized protein LOC122556575 isoform X1
uncharacterized protein LOC122556575 isoform X6
uncharacterized protein LOC122556575 isoform X2
uncharacterized protein LOC122556575 isoform X4
uncharacterized protein LOC122556575 isoform X3
uncharacterized protein LOC122556575 isoform X7
uncharacterized LOC122556575, transcript variant X8
uncharacterized LOC122556575, transcript variant X9
uncharacterized LOC122556575, transcript variant X10
uncharacterized protein LOC122556575 isoform X9
uncharacterized protein LOC122556575 isoform X8
folliculin interacting protein 1, transcript variant X1
folliculin interacting protein 1, transcript variant X2
folliculin-interacting protein 1 isoform X1
folliculin-interacting protein 1 isoform X2
folliculin interacting protein 1, transcript variant X3
folliculin-interacting protein 1 isoform X3
folliculin interacting protein 1, transcript variant X4
folliculin-interacting protein 1 isoform X4
rap guanine nucleotide exchange factor 6-like, transcript variant X9
rap guanine nucleotide exchange factor 6-like, transcript variant X2
rap guanine nucleotide exchange factor 6-like, transcript variant X5
rap guanine nucleotide exchange factor 6-like, transcript variant X3
rap guanine nucleotide exchange factor 6-like, transcript variant X1
rap guanine nucleotide exchange factor 6-like, transcript variant X4
rap guanine nucleotide exchange factor 6-like isoform X9
rap guanine nucleotide exchange factor 6-like isoform X2
rap guanine nucleotide exchange factor 6-like isoform X5
rap guanine nucleotide exchange factor 6-like isoform X3
rap guanine nucleotide exchange factor 6-like isoform X1
rap guanine nucleotide exchange factor 6-like isoform X4
rap guanine nucleotide exchange factor 6-like, transcript variant X6
rap guanine nucleotide exchange factor 6-like, transcript variant X7
rap guanine nucleotide exchange factor 6-like, transcript variant X8
rap guanine nucleotide exchange factor 6-like isoform X6
rap guanine nucleotide exchange factor 6-like isoform X8
rap guanine nucleotide exchange factor 6-like isoform X7
follistatin-related protein 5-like, transcript variant X2
follistatin-related protein 5-like, transcript variant X1
follistatin-related protein 5-like isoform X2
follistatin-related protein 5-like isoform X1
keratinocyte-associated transmembrane protein 2
voltage-dependent anion channel 1, transcript variant X1
voltage-dependent anion channel 1, transcript variant X2
voltage-dependent anion-selective channel protein 1
uncharacterized LOC122556907, transcript variant X2
uncharacterized LOC122556907, transcript variant X1
cytochrome P450 2U1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cytochrome P450 2U1-like, transcript variant X1
transcription factor 7, transcript variant X1
transcription factor 7, transcript variant X2
transcription factor 7, transcript variant X4
transcription factor 7, transcript variant X3
transcription factor 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transcription factor 7, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transcription factor 7, transcript variant X6
S-phase kinase-associated protein 1, transcript variant X8
S-phase kinase-associated protein 1, transcript variant X6
S-phase kinase-associated protein 1, transcript variant X5
S-phase kinase-associated protein 1, transcript variant X3
S-phase kinase-associated protein 1, transcript variant X4
S-phase kinase-associated protein 1, transcript variant X1
S-phase kinase-associated protein 1, transcript variant X7
S-phase kinase-associated protein 1, transcript variant X2
S-phase kinase-associated protein 1 isoform X1
S-phase kinase-associated protein 1 isoform X2
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
CDKN2A interacting protein N-terminal like
secretion associated, Ras related GTPase 1B
jade family PHD finger 2, transcript variant X2
jade family PHD finger 2, transcript variant X1
SEC24 homolog A, COPII coat complex component
calcium modulating ligand, transcript variant X4
calcium modulating ligand, transcript variant X2
calcium modulating ligand, transcript variant X3
calcium modulating ligand, transcript variant X1
calcium signal-modulating cyclophilin ligand isoform X1
calcium signal-modulating cyclophilin ligand isoform X2
calcium signal-modulating cyclophilin ligand isoform X3
calcium signal-modulating cyclophilin ligand isoform X4
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46, transcript variant X1
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46, transcript variant X2
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46, transcript variant X3
probable ATP-dependent RNA helicase DDX46 isoform X1
probable ATP-dependent RNA helicase DDX46 isoform X2
probable ATP-dependent RNA helicase DDX46 isoform X3
UPF0461 protein C5orf24 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
UPF0461 protein C5orf24 homolog, transcript variant X3
UPF0461 protein C5orf24 homolog, transcript variant X1
UPF0461 protein C5orf24 homolog isoform X5
UPF0461 protein C5orf24 homolog isoform X1
UPF0461 protein C5orf24 homolog, transcript variant X4
UPF0461 protein C5orf24 homolog isoform X3
UPF0461 protein C5orf24 homolog, transcript variant X2
UPF0461 protein C5orf24 homolog isoform X2
UPF0461 protein C5orf24 homolog isoform X4
thioredoxin domain-containing protein 15
pterin-4-alpha-carbinolamine dehydratase 2-like, transcript variant X4
pterin-4-alpha-carbinolamine dehydratase 2-like, transcript variant X3
pterin-4-alpha-carbinolamine dehydratase 2-like, transcript variant X2
pterin-4-alpha-carbinolamine dehydratase 2-like, transcript variant X1
pterin-4-alpha-carbinolamine dehydratase 2-like isoform X1
pterin-4-alpha-carbinolamine dehydratase 2-like isoform X2
cation channel sperm-associated protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
paired-like homeodomain 1, transcript variant X2
paired-like homeodomain 1, transcript variant X3
paired-like homeodomain 1, transcript variant X1
core histone macro-H2A.1, transcript variant X4
core histone macro-H2A.1, transcript variant X1
core histone macro-H2A.1, transcript variant X2
core histone macro-H2A.1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
solute carrier family 25 member 48, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
solute carrier family 25 member 48, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
solute carrier family 25 member 48, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
solute carrier family 25 member 48 isoform X1
solute carrier family 25 member 48 isoform X2
uncharacterized LOC122556602, transcript variant X3
uncharacterized LOC122556602, transcript variant X2
uncharacterized LOC122556602, transcript variant X1
F-box/LRR-repeat protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
F-box/LRR-repeat protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
transforming growth factor, beta-induced
transforming growth factor-beta-induced protein ig-h3
potassium channel tetramerization domain containing 16b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD16b isoform X1
potassium channel tetramerization domain containing 16b, transcript variant X2
BTB/POZ domain-containing protein KCTD16b isoform X2
Yip1 domain family, member 5, transcript variant X2
Yip1 domain family, member 5, transcript variant X5
Yip1 domain family, member 5, transcript variant X7
Yip1 domain family, member 5, transcript variant X4
Yip1 domain family, member 5, transcript variant X3
Yip1 domain family, member 5, transcript variant X6
Yip1 domain family, member 5, transcript variant X1
progesterone receptor-like, transcript variant X2
progesterone receptor-like, transcript variant X1
progesterone receptor-like, transcript variant X3
rho GTPase-activating protein 26-like, transcript variant X8
rho GTPase-activating protein 26-like, transcript variant X3
rho GTPase-activating protein 26-like, transcript variant X6
rho GTPase-activating protein 26-like, transcript variant X5
rho GTPase-activating protein 26-like, transcript variant X2
rho GTPase-activating protein 26-like, transcript variant X1
rho GTPase-activating protein 26-like, transcript variant X7
rho GTPase-activating protein 26-like, transcript variant X4
rho GTPase-activating protein 26-like isoform X8
rho GTPase-activating protein 26-like isoform X7
rho GTPase-activating protein 26-like isoform X6
rho GTPase-activating protein 26-like isoform X5
rho GTPase-activating protein 26-like isoform X4
rho GTPase-activating protein 26-like isoform X3
rho GTPase-activating protein 26-like isoform X2
rho GTPase-activating protein 26-like isoform X1
rho GTPase-activating protein 26-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho GTPase-activating protein 26-like, transcript variant X9
rho GTPase-activating protein 26-like isoform X9
rho GTPase-activating protein 26-like, transcript variant X11
rho GTPase-activating protein 26-like isoform X10
polypeptide N-acetylgalactosaminyltransferase 10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 10-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 10-like isoform X2
polypeptide N-acetylgalactosaminyltransferase 10-like isoform X1
microfibril-associated glycoprotein 3-like, transcript variant X2
microfibril-associated glycoprotein 3-like, transcript variant X1
microfibril-associated glycoprotein 3-like
family with sequence similarity 114 member A2, transcript variant X3
family with sequence similarity 114 member A2, transcript variant X1
family with sequence similarity 114 member A2, transcript variant X2
family with sequence similarity 114 member A2, transcript variant X4
family with sequence similarity 114 member A2, transcript variant X5
CCR4-NOT transcription complex, subunit 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 8
mothers against decapentaplegic homolog 5
short transient receptor potential channel 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
methylsterol monooxygenase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
methylsterol monooxygenase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
methylsterol monooxygenase 1-like isoform X1
methylsterol monooxygenase 1-like isoform X2
kelch-like protein 3, transcript variant X12
kelch-like protein 3, transcript variant X3
kelch-like protein 3, transcript variant X10
kelch-like protein 3, transcript variant X4
kelch-like protein 3, transcript variant X1
kelch-like protein 3, transcript variant X9
kelch-like protein 3, transcript variant X7
kelch-like protein 3, transcript variant X6
kelch-like protein 3, transcript variant X8
kelch-like protein 3, transcript variant X13
kelch-like protein 3, transcript variant X14
kelch-like protein 3, transcript variant X5
kelch-like protein 3, transcript variant X2
kelch-like protein 3, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins
heterogeneous nuclear ribonucleoprotein A3-like
neuropeptide Y receptor type 6-like, transcript variant X2
neuropeptide Y receptor type 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
polycystic kidney disease 2-like 2 protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
protein FAM13B-like, transcript variant X1
protein FAM13B-like, transcript variant X2
thymosin beta-11-like, transcript variant X1
thymosin beta-11-like, transcript variant X2
guanine nucleotide-binding protein subunit beta-2-like 1
NME/NM23 family member 5, transcript variant X1
NME/NM23 family member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nucleoside diphosphate kinase homolog 5 isoform X2
nucleoside diphosphate kinase homolog 5 isoform X1
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein Wnt-8-like, transcript variant X6
protein Wnt-8-like, transcript variant X1
protein Wnt-8-like, transcript variant X7
protein Wnt-8-like, transcript variant X3
protein Wnt-8-like, transcript variant X4
protein Wnt-8-like, transcript variant X5
protein Wnt-8-like, transcript variant X2
protein Wnt-8-like, transcript variant X8
heterogeneous nuclear ribonucleoprotein A/Ba, transcript variant X3
heterogeneous nuclear ribonucleoprotein A/Ba, transcript variant X2
heterogeneous nuclear ribonucleoprotein A/Ba, transcript variant X1
heterogeneous nuclear ribonucleoprotein A/Ba isoform X1
heterogeneous nuclear ribonucleoprotein A/Ba isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
collagen alpha-1(XXIII) chain-like, transcript variant X3
collagen alpha-1(XXIII) chain-like, transcript variant X2
collagen alpha-1(XXIII) chain-like, transcript variant X1
collagen alpha-1(XXIII) chain-like isoform X2
collagen alpha-1(XXIII) chain-like isoform X3
collagen alpha-1(XXIII) chain-like isoform X1
CDC-like kinase 4a, transcript variant X1
CDC-like kinase 4a, transcript variant X3
CDC-like kinase 4a, transcript variant X2
dual specificity protein kinase CLK4 isoform X1
dual specificity protein kinase CLK4 isoform X2
ras-GEF domain-containing family member 1C-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ras-GEF domain-containing family member 1C-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ras-GEF domain-containing family member 1C-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ras-GEF domain-containing family member 1C-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ras-GEF domain-containing family member 1C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ras-GEF domain-containing family member 1C-like isoform X2
ras-GEF domain-containing family member 1C-like isoform X1
mitogen-activated protein kinase 9, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X8
mitogen-activated protein kinase 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X6
mitogen-activated protein kinase 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 118 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mitogen-activated protein kinase 9 isoform X1
mitogen-activated protein kinase 9 isoform X5
mitogen-activated protein kinase 9 isoform X2
mitogen-activated protein kinase 9 isoform X4
mitogen-activated protein kinase 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitogen-activated protein kinase 9 isoform X3
mitogen-activated protein kinase 9, transcript variant X11
mitogen-activated protein kinase 9 isoform X6
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like, transcript variant X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like isoform X2
CCR4-NOT transcription complex subunit 6, transcript variant X1
CCR4-NOT transcription complex subunit 6, transcript variant X2
CCR4-NOT transcription complex subunit 6, transcript variant X3
CCR4-NOT transcription complex subunit 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
eukaryotic translation initiation factor 4E-binding protein 3-like
ankyrin repeat and KH domain containing 1, transcript variant X19
ankyrin repeat and KH domain containing 1, transcript variant X13
ankyrin repeat and KH domain containing 1, transcript variant X12
ankyrin repeat and KH domain containing 1, transcript variant X3
ankyrin repeat and KH domain containing 1, transcript variant X5
ankyrin repeat and KH domain containing 1, transcript variant X4
ankyrin repeat and KH domain containing 1, transcript variant X15
ankyrin repeat and KH domain containing 1, transcript variant X11
ankyrin repeat and KH domain containing 1, transcript variant X10
ankyrin repeat and KH domain containing 1, transcript variant X7
ankyrin repeat and KH domain containing 1, transcript variant X9
ankyrin repeat and KH domain containing 1, transcript variant X8
ankyrin repeat and KH domain containing 1, transcript variant X6
ankyrin repeat and KH domain containing 1, transcript variant X2
ankyrin repeat and KH domain containing 1, transcript variant X1
ankyrin repeat and KH domain containing 1, transcript variant X20
ankyrin repeat and KH domain containing 1, transcript variant X17
ankyrin repeat and KH domain containing 1, transcript variant X16
ankyrin repeat and KH domain containing 1, transcript variant X18
ankyrin repeat and KH domain containing 1, transcript variant X14
ankyrin repeat and KH domain-containing protein 1 isoform X20
ankyrin repeat and KH domain-containing protein 1 isoform X18
ankyrin repeat and KH domain-containing protein 1 isoform X19
ankyrin repeat and KH domain-containing protein 1 isoform X11
ankyrin repeat and KH domain-containing protein 1 isoform X13
ankyrin repeat and KH domain-containing protein 1 isoform X12
ankyrin repeat and KH domain-containing protein 1 isoform X10
ankyrin repeat and KH domain-containing protein 1 isoform X7
ankyrin repeat and KH domain-containing protein 1 isoform X9
ankyrin repeat and KH domain-containing protein 1 isoform X8
ankyrin repeat and KH domain-containing protein 1 isoform X6
ankyrin repeat and KH domain-containing protein 1 isoform X17
ankyrin repeat and KH domain-containing protein 1 isoform X16
ankyrin repeat and KH domain-containing protein 1 isoform X3
ankyrin repeat and KH domain-containing protein 1 isoform X5
ankyrin repeat and KH domain-containing protein 1 isoform X4
ankyrin repeat and KH domain-containing protein 1 isoform X15
ankyrin repeat and KH domain-containing protein 1 isoform X2
ankyrin repeat and KH domain-containing protein 1 isoform X1
ankyrin repeat and KH domain-containing protein 1 isoform X14
uncharacterized LOC122556651, transcript variant X1
electrogenic sodium bicarbonate cotransporter 1-like
uncharacterized LOC122556651, transcript variant X2
deoxynucleoside kinase, transcript variant X3
deoxynucleoside kinase, transcript variant X2
deoxynucleoside kinase, transcript variant X1
heterogeneous nuclear ribonucleoprotein H1, like
RUN and FYVE domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RUN and FYVE domain-containing protein 1 isoform X4
RUN and FYVE domain containing 1, transcript variant X3
RUN and FYVE domain containing 1, transcript variant X1
RUN and FYVE domain containing 1, transcript variant X2
RUN and FYVE domain-containing protein 1 isoform X2
RUN and FYVE domain-containing protein 1 isoform X3
RUN and FYVE domain-containing protein 1 isoform X1
prefoldin subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
prefoldin subunit 1, transcript variant X3
prefoldin subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
cysteine-rich and transmembrane domain-containing protein 1-like, transcript variant X3
cysteine-rich and transmembrane domain-containing protein 1-like isoform X3
cysteine-rich and transmembrane domain-containing protein 1-like, transcript variant X2
cysteine-rich and transmembrane domain-containing protein 1-like, transcript variant X1
cysteine-rich and transmembrane domain-containing protein 1-like isoform X2
uncharacterized protein LOC122556657 isoform X1
prostate androgen-regulated mucin-like protein 1 homolog
uncharacterized LOC122556660, transcript variant X6
uncharacterized LOC122556660, transcript variant X5
uncharacterized LOC122556660, transcript variant X4
uncharacterized LOC122556660, transcript variant X1
uncharacterized LOC122556660, transcript variant X3
uncharacterized LOC122556660, transcript variant X2
pro-neuregulin-2, membrane-bound isoform-like, transcript variant X1
pro-neuregulin-2, membrane-bound isoform-like, transcript variant X2
pro-neuregulin-2, membrane-bound isoform-like isoform X1
pro-neuregulin-2, membrane-bound isoform-like isoform X2
uncharacterized LOC122556663, transcript variant X2
uncharacterized LOC122556663, transcript variant X1
uncharacterized LOC122556663, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
pleckstrin and Sec7 domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pleckstrin and Sec7 domain containing 2, transcript variant X1
PH and SEC7 domain-containing protein 2 isoform X2
PH and SEC7 domain-containing protein 2 isoform X1
CXXC finger protein 5a, transcript variant X7
CXXC finger protein 5a, transcript variant X13
CXXC finger protein 5a, transcript variant X5
CXXC finger protein 5a, transcript variant X11
CXXC finger protein 5a, transcript variant X9
CXXC finger protein 5a, transcript variant X1
CXXC finger protein 5a, transcript variant X3
CXXC finger protein 5a, transcript variant X12
CXXC finger protein 5a, transcript variant X4
CXXC finger protein 5a, transcript variant X10
CXXC finger protein 5a, transcript variant X2
CXXC finger protein 5a, transcript variant X8
CXXC finger protein 5a, transcript variant X6
CDGSH iron-sulfur domain-containing protein 1-like
ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast), transcript variant X2
ubiquitin-conjugating enzyme E2 D2 isoform X2
ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast), transcript variant X3
ubiquitin-conjugating enzyme E2 D2 isoform X3
ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast), transcript variant X1
ubiquitin-conjugating enzyme E2 D2 isoform X1
ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast), transcript variant X4
ubiquitin-conjugating enzyme E2 D2 isoform X4
nuclear factor NF-kappa-B p105 subunit-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear factor NF-kappa-B p105 subunit-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nuclear factor NF-kappa-B p105 subunit-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nuclear factor NF-kappa-B p105 subunit-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear factor NF-kappa-B p105 subunit-like, transcript variant X5
nuclear factor NF-kappa-B p105 subunit-like isoform X2
nuclear factor NF-kappa-B p105 subunit-like isoform X4
nuclear factor NF-kappa-B p105 subunit-like isoform X1
nuclear factor NF-kappa-B p105 subunit-like isoform X3
nuclear factor NF-kappa-B p105 subunit-like isoform X5
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant X1
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant X3
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant X2
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant X4
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant X5
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant X7
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X4
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X5
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X7
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant X6
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X6
stimulator of interferon response cGAMP interactor 1, transcript variant X1
stimulator of interferon genes protein isoform X1
stimulator of interferon response cGAMP interactor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
stimulator of interferon genes protein isoform X2
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X1
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X2
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X3
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X4
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X5
endothelial cell-specific chemotaxis regulator isoform X1
endothelial cell-specific chemotaxis regulator isoform X2
endothelial cell-specific chemotaxis regulator isoform X3
endothelial cell-specific chemotaxis regulator isoform X4
endothelial cell-specific chemotaxis regulator isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
DNA damage-inducible transcript 4-like protein-like
DnaJ (Hsp40) homolog, subfamily C, member 18, transcript variant X1
dnaJ homolog subfamily C member 18 isoform X1
DnaJ (Hsp40) homolog, subfamily C, member 18, transcript variant X3
dnaJ homolog subfamily C member 18 isoform X3
DnaJ (Hsp40) homolog, subfamily C, member 18, transcript variant X2
dnaJ homolog subfamily C member 18 isoform X2
solute carrier family 23 member 1-like, transcript variant X1
solute carrier family 23 member 1-like, transcript variant X2
solute carrier family 23 member 1-like isoform X1
solute carrier family 23 member 1-like isoform X2
solute carrier family 23 member 1-like, transcript variant X6
solute carrier family 23 member 1-like, transcript variant X5
solute carrier family 23 member 1-like, transcript variant X4
solute carrier family 23 member 1-like, transcript variant X3
solute carrier family 23 member 1-like isoform X3
solute carrier family 23 member 1-like, transcript variant X7
solute carrier family 23 member 1-like isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
glutamate receptor ionotropic, delta-2-like, transcript variant X1
glutamate receptor ionotropic, delta-2-like, transcript variant X3
glutamate receptor ionotropic, delta-2-like, transcript variant X2
glutamate receptor ionotropic, delta-2-like, transcript variant X4
glutamate receptor ionotropic, delta-2-like, transcript variant X5
glutamate receptor ionotropic, delta-2-like isoform X1
glutamate receptor ionotropic, delta-2-like isoform X2
glutamate receptor ionotropic, delta-2-like isoform X3
glutamate receptor ionotropic, delta-2-like, transcript variant X6
glutamate receptor ionotropic, delta-2-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PDZ and LIM domain 7, transcript variant X2
PDZ and LIM domain 7, transcript variant X4
PDZ and LIM domain 7, transcript variant X1
PDZ and LIM domain 7, transcript variant X3
PDZ and LIM domain 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 19% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC122556996
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
eukaryotic translation initiation factor 4E-1A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
eukaryotic translation initiation factor 4E-1A-like, transcript variant X1
eukaryotic translation initiation factor 4E-1A-like isoform X2
eukaryotic translation initiation factor 4E-1A-like isoform X1
eukaryotic translation initiation factor 4E-1A-like, transcript variant X3
eukaryotic translation initiation factor 4E-1A-like isoform X3
G protein-regulated inducer of neurite outgrowth 3, transcript variant X5
uncharacterized LOC122556690, transcript variant X2
uncharacterized LOC122556690, transcript variant X3
uncharacterized LOC122556690, transcript variant X1
G protein-regulated inducer of neurite outgrowth 3, transcript variant X1
G protein-regulated inducer of neurite outgrowth 3, transcript variant X2
G protein-regulated inducer of neurite outgrowth 3, transcript variant X4
G protein-regulated inducer of neurite outgrowth 3, transcript variant X3
G protein-regulated inducer of neurite outgrowth 3
ring finger protein 44, transcript variant X1
ring finger protein 44, transcript variant X2
ring finger protein 44, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ring finger protein 44, transcript variant X3
ring finger protein 44, transcript variant X9
ring finger protein 44, transcript variant X8
ring finger protein 44, transcript variant X7
ring finger protein 44, transcript variant X6
ring finger protein 44, transcript variant X5
clathrin light chain B-like, transcript variant X1
clathrin light chain B-like, transcript variant X2
HIG1 hypoxia inducible domain family, member 2A
HIG1 domain family member 2A, mitochondrial
SUMO interacting motifs containing 1, transcript variant X3
SUMO interacting motifs containing 1, transcript variant X2
SUMO interacting motifs containing 1, transcript variant X1
SUMO-interacting motif-containing protein 1 isoform X3
SUMO-interacting motif-containing protein 1 isoform X2
SUMO-interacting motif-containing protein 1 isoform X1
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122556701, transcript variant X4
uncharacterized LOC122556701, transcript variant X3
uncharacterized LOC122556701, transcript variant X2
uncharacterized LOC122556701, transcript variant X1
uncharacterized LOC122556700, transcript variant X2
uncharacterized LOC122556700, transcript variant X1
histamine H2 receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
histamine H2 receptor-like, transcript variant X2
uncharacterized LOC122556925, transcript variant X2
uncharacterized LOC122556925, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
casein kinase 1, alpha 1, transcript variant X2
casein kinase 1, alpha 1, transcript variant X1
casein kinase 1, alpha 1, transcript variant X3
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X3
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X4
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X5
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X2
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X6
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X8
rho guanine nucleotide exchange factor 37 isoform X4
rho guanine nucleotide exchange factor 37 isoform X2
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X1
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X9
rho guanine nucleotide exchange factor 37 isoform X1
rho guanine nucleotide exchange factor 37 isoform X5
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X7
rho guanine nucleotide exchange factor 37 isoform X3
peroxisome proliferator-activated receptor gamma, coactivator 1 beta, transcript variant X1
peroxisome proliferator-activated receptor gamma, coactivator 1 beta, transcript variant X2
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X1
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X2
E3 ubiquitin-protein ligase TRIM8-like, transcript variant X4
E3 ubiquitin-protein ligase TRIM8-like, transcript variant X1
E3 ubiquitin-protein ligase TRIM8-like, transcript variant X3
E3 ubiquitin-protein ligase TRIM8-like, transcript variant X2
E3 ubiquitin-protein ligase TRIM8-like isoform X2
uncharacterized protein LOC122556712 isoform X1
phosphodiesterase 6A, cGMP-specific, rod, alpha
rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha
5-hydroxytryptamine receptor 4, transcript variant X1
5-hydroxytryptamine receptor 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
5-hydroxytryptamine receptor 4, transcript variant X4
5-hydroxytryptamine receptor 4, transcript variant X2
5-hydroxytryptamine receptor 4 isoform X1
5-hydroxytryptamine receptor 4 isoform X3
5-hydroxytryptamine receptor 4 isoform X2
5-hydroxytryptamine receptor 4 isoform X4
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X11
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X9
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X10
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X4
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X7
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X3
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X1
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X8
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X6
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X5
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X2
endoplasmic reticulum-Golgi intermediate compartment protein 1
neuralized E3 ubiquitin protein ligase 1B, transcript variant X1
E3 ubiquitin-protein ligase NEURL1B isoform X1
neuralized E3 ubiquitin protein ligase 1B, transcript variant X2
E3 ubiquitin-protein ligase NEURL1B isoform X2
SH3 and PX domains 2B, transcript variant X1
SH3 and PX domains 2B, transcript variant X2
SH3 and PX domain-containing protein 2B isoform X2
SH3 and PX domain-containing protein 2B isoform X1
serine/threonine kinase 10, transcript variant X2
serine/threonine kinase 10, transcript variant X1
serine/threonine-protein kinase 10 isoform X2
serine/threonine-protein kinase 10 isoform X1
EF-hand calcium-binding domain-containing protein 9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin domain containing 2, transcript variant X1
ubiquitin domain containing 2, transcript variant X2
ubiquitin domain containing 2, transcript variant X3
ubiquitin domain-containing protein 2 isoform X1
ubiquitin domain-containing protein 2 isoform X2
ubiquitin domain-containing protein 2 isoform X3
SH3 domain and tetratricopeptide repeat-containing protein 2-like, transcript variant X3
SH3 domain and tetratricopeptide repeat-containing protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
SH3 domain and tetratricopeptide repeat-containing protein 2-like, transcript variant X1
SH3 domain and tetratricopeptide repeat-containing protein 2-like, transcript variant X4
SH3 domain and tetratricopeptide repeat-containing protein 2-like isoform X3
SH3 domain and tetratricopeptide repeat-containing protein 2-like isoform X2
SH3 domain and tetratricopeptide repeat-containing protein 2-like isoform X1
SH3 domain and tetratricopeptide repeat-containing protein 2-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
actin binding LIM protein family, member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
actin binding LIM protein family, member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
actin binding LIM protein family, member 3, transcript variant X6
actin binding LIM protein family, member 3, transcript variant X3
actin binding LIM protein family, member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
actin binding LIM protein family, member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
actin binding LIM protein family, member 3, transcript variant X7
actin binding LIM protein family, member 3, transcript variant X8
actin filament associated protein 1-like 1a, transcript variant X3
actin filament-associated protein 1-like 1 isoform X3
actin filament associated protein 1-like 1a, transcript variant X1
actin filament-associated protein 1-like 1 isoform X1
actin filament associated protein 1-like 1a, transcript variant X4
actin filament-associated protein 1-like 1 isoform X4
actin filament associated protein 1-like 1a, transcript variant X2
actin filament-associated protein 1-like 1 isoform X2
grpE protein homolog 1, mitochondrial-like
uncharacterized protein KIAA0232-like, transcript variant X2
uncharacterized protein KIAA0232-like, transcript variant X1
uncharacterized protein KIAA0232-like isoform X2
uncharacterized protein KIAA0232-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122556739, transcript variant X2
uncharacterized LOC122556739, transcript variant X1
neuronal vesicle trafficking associated 2, transcript variant X2
neuronal vesicle trafficking associated 2, transcript variant X1
neuronal vesicle trafficking-associated protein 2
PTTG1 regulator of sister chromatid separation, securin, transcript variant X1
PTTG1 regulator of sister chromatid separation, securin, transcript variant X2
PTTG1 regulator of sister chromatid separation, securin, transcript variant X3
ribosomal protein L26, transcript variant X1
ribosomal protein L26, transcript variant X2
uncharacterized LOC122556932, transcript variant X1
uncharacterized LOC122556932, transcript variant X2
creb3 regulatory factor, transcript variant X1
creb3 regulatory factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
creb3 regulatory factor, transcript variant X3
BCL2 interacting protein 1b, transcript variant X2
BCL2 interacting protein 1b, transcript variant X1
BCL2 interacting protein 1b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
vesicle transport protein SEC20 isoform X2
vesicle transport protein SEC20 isoform X1
vesicle transport protein SEC20 isoform X4
BCL2 interacting protein 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
vesicle transport protein SEC20 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122556752, transcript variant X1
uncharacterized LOC122556752, transcript variant X2
biorientation of chromosomes in cell division 1, transcript variant X1
biorientation of chromosomes in cell division 1, transcript variant X4
biorientation of chromosomes in cell division 1, transcript variant X3
biorientation of chromosomes in cell division 1, transcript variant X2
biorientation of chromosomes in cell division 1, transcript variant X5
biorientation of chromosomes in cell division 1, transcript variant X6
biorientation of chromosomes in cell division protein 1 isoform X3
biorientation of chromosomes in cell division protein 1 isoform X1
biorientation of chromosomes in cell division protein 1 isoform X4
biorientation of chromosomes in cell division protein 1 isoform X2
uncharacterized LOC122556751, transcript variant X2
uncharacterized LOC122556751, transcript variant X3
uncharacterized LOC122556751, transcript variant X1
cytoplasmic polyadenylation element binding protein 4b, transcript variant X1
cytoplasmic polyadenylation element binding protein 4b, transcript variant X3
cytoplasmic polyadenylation element binding protein 4b, transcript variant X2
cytoplasmic polyadenylation element binding protein 4b, transcript variant X4
cytoplasmic polyadenylation element-binding protein 4b isoform X1
cytoplasmic polyadenylation element-binding protein 4b isoform X3
cytoplasmic polyadenylation element-binding protein 4b isoform X2
cytoplasmic polyadenylation element-binding protein 4b isoform X4
cytoplasmic polyadenylation element binding protein 4b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cytoplasmic polyadenylation element-binding protein 4b isoform X6
cytoplasmic polyadenylation element binding protein 4b, transcript variant X5
cytoplasmic polyadenylation element-binding protein 4b isoform X5
uncharacterized LOC122556754, transcript variant X3
uncharacterized LOC122556754, transcript variant X1
uncharacterized LOC122556754, transcript variant X4
uncharacterized LOC122556754, transcript variant X2
uncharacterized LOC122556754, transcript variant X5
SLU7 homolog, splicing factor, transcript variant X3
SLU7 homolog, splicing factor, transcript variant X2
SLU7 homolog, splicing factor, transcript variant X1
pre-mRNA-splicing factor SLU7 isoform X1
pre-mRNA-splicing factor SLU7 isoform X2
C1q and TNF related 2, transcript variant X1
C1q and TNF related 2, transcript variant X2
complement C1q tumor necrosis factor-related protein 2
fatty acid binding protein 6, ileal (gastrotropin)
gastrotropin-like, transcript variant X3
gastrotropin-like, transcript variant X1
gastrotropin-like, transcript variant X2
PWWP domain containing 2A, transcript variant X1
PWWP domain containing 2A, transcript variant X3
PWWP domain containing 2A, transcript variant X2
PWWP domain-containing protein 2A isoform X1
PWWP domain-containing protein 2A isoform X3
PWWP domain-containing protein 2A isoform X2
PWWP domain containing 2A, transcript variant X4
PWWP domain containing 2A, transcript variant X5
PWWP domain-containing protein 2A isoform X4
PWWP domain-containing protein 2A isoform X5
PWWP domain containing 2A, transcript variant X6
PWWP domain containing 2A, transcript variant X7
PWWP domain-containing protein 2A isoform X6
PWWP domain-containing protein 2A isoform X7
tetratricopeptide repeat domain 1, transcript variant X1
tetratricopeptide repeat domain 1, transcript variant X2
catenin (cadherin-associated protein), alpha 1, transcript variant X1
catenin (cadherin-associated protein), alpha 1, transcript variant X2
leucine rich repeat transmembrane neuronal 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
leucine-rich repeat transmembrane neuronal protein 2
catenin (cadherin-associated protein), alpha 1, transcript variant X3
mitotic spindle assembly checkpoint protein MAD1-like
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
single-stranded DNA-binding protein, mitochondrial
uncharacterized LOC122556767, transcript variant X1
uncharacterized LOC122556767, transcript variant X2
uncharacterized LOC122556767, transcript variant X3
pantothenate kinase 3, transcript variant X2
pantothenate kinase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
G protein-coupled receptor kinase 6-like, transcript variant X2
G protein-coupled receptor kinase 6-like, transcript variant X4
G protein-coupled receptor kinase 6-like, transcript variant X3
G protein-coupled receptor kinase 6-like, transcript variant X1
G protein-coupled receptor kinase 6-like, transcript variant X6
G protein-coupled receptor kinase 6-like isoform X1
G protein-coupled receptor kinase 6-like isoform X3
G protein-coupled receptor kinase 6-like, transcript variant X5
G protein-coupled receptor kinase 6-like isoform X2
G protein-coupled receptor kinase 6-like, transcript variant X7
G protein-coupled receptor kinase 6-like isoform X4
hexokinase-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hexokinase-1-like, transcript variant X1
hexokinase-1-like, transcript variant X3
ubiquitin interaction motif containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
polyadenylate-binding protein-interacting protein 2-like, transcript variant X1
polyadenylate-binding protein-interacting protein 2-like, transcript variant X3
polyadenylate-binding protein-interacting protein 2-like, transcript variant X4
polyadenylate-binding protein-interacting protein 2-like, transcript variant X6
polyadenylate-binding protein-interacting protein 2-like, transcript variant X5
polyadenylate-binding protein-interacting protein 2-like, transcript variant X2
polyadenylate-binding protein-interacting protein 2-like
Kv channel-interacting protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Kv channel-interacting protein 1-like, transcript variant X2
Kv channel-interacting protein 1-like, transcript variant X4
Kv channel-interacting protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Kv channel-interacting protein 1-like isoform X3
Kv channel-interacting protein 1-like isoform X2
Kv channel-interacting protein 1-like isoform X1
Kv channel-interacting protein 1-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
lymphocyte cytosolic protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
lymphocyte cytosolic protein 2-like, transcript variant X2
lymphocyte cytosolic protein 2-like isoform X1
lymphocyte cytosolic protein 2-like isoform X2
kazal-type serine protease inhibitor domain-containing protein 1-like, transcript variant X5
kazal-type serine protease inhibitor domain-containing protein 1-like, transcript variant X2
kazal-type serine protease inhibitor domain-containing protein 1-like, transcript variant X4
kazal-type serine protease inhibitor domain-containing protein 1-like, transcript variant X3
kazal-type serine protease inhibitor domain-containing protein 1-like, transcript variant X1
kazal-type serine protease inhibitor domain-containing protein 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
kazal-type serine protease inhibitor domain-containing protein 1-like
ran-binding protein 17-like, transcript variant X1
ran-binding protein 17-like, transcript variant X2
ran-binding protein 17-like, transcript variant X3
T-cell leukemia homeobox protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
T-cell leukemia homeobox protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
T-cell leukemia homeobox protein 3-like, transcript variant X2
T-cell leukemia homeobox protein 3-like isoform X1
T-cell leukemia homeobox protein 3-like isoform X2
uncharacterized LOC122556941, transcript variant X1
uncharacterized LOC122556941, transcript variant X2
uncharacterized protein LOC122556941 isoform X1
uncharacterized protein LOC122556941 isoform X2
F-box/WD repeat-containing protein 11, transcript variant X2
F-box/WD repeat-containing protein 11, transcript variant X1
F-box/WD repeat-containing protein 11, transcript variant X6
F-box/WD repeat-containing protein 11, transcript variant X3
F-box/WD repeat-containing protein 11, transcript variant X5
F-box/WD repeat-containing protein 11, transcript variant X7
F-box/WD repeat-containing protein 11, transcript variant X4
F-box/WD repeat-containing protein 11, transcript variant X8
F-box/WD repeat-containing protein 11 isoform X2
F-box/WD repeat-containing protein 11 isoform X1
F-box/WD repeat-containing protein 11 isoform X3
F-box/WD repeat-containing protein 11 isoform X4
F-box/WD repeat-containing protein 11 isoform X5
nucleophosmin-like, transcript variant X2
nucleophosmin-like, transcript variant X1
programmed cell death protein 4-like, transcript variant X2
programmed cell death protein 4-like, transcript variant X3
programmed cell death protein 4-like, transcript variant X1
programmed cell death protein 4-like isoform X2
programmed cell death protein 4-like isoform X3
programmed cell death protein 4-like isoform X1
vesicular integral-membrane protein VIP36
eukaryotic peptide chain release factor subunit 1, transcript variant X2
eukaryotic peptide chain release factor subunit 1, transcript variant X1
eukaryotic peptide chain release factor subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
apoptosis-associated speck-like protein containing a CARD
serine/threonine-protein kinase 32A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
serine/threonine-protein kinase 32A-like isoform X1
serine/threonine-protein kinase 32A-like, transcript variant X2
serine/threonine-protein kinase 32B-like isoform X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform, transcript variant X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform, transcript variant X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform, transcript variant X4
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X4
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform, transcript variant X7
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X7
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform, transcript variant X5
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X5
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform, transcript variant X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform, transcript variant X6
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
transcription elongation regulator 1b (CA150), transcript variant X2
transcription elongation regulator 1b (CA150), transcript variant X4
transcription elongation regulator 1b (CA150), transcript variant X1
transcription elongation regulator 1b (CA150), transcript variant X6
transcription elongation regulator 1b (CA150), transcript variant X3
transcription elongation regulator 1b (CA150), transcript variant X5
transcription elongation regulator 1 isoform X6
transcription elongation regulator 1 isoform X5
transcription elongation regulator 1 isoform X4
transcription elongation regulator 1 isoform X3
transcription elongation regulator 1 isoform X2
transcription elongation regulator 1 isoform X1
EBF transcription factor 1a, transcript variant X4
EBF transcription factor 1a, transcript variant X2
EBF transcription factor 1a, transcript variant X1
EBF transcription factor 1a, transcript variant X3
uncharacterized LOC122556792, transcript variant X2
uncharacterized LOC122556792, transcript variant X1
clathrin interactor 1a, transcript variant X1
clathrin interactor 1a, transcript variant X2
clathrin interactor 1a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
U7 snRNA-associated Sm-like protein LSm11
tRNA-histidine guanylyltransferase 1-like, transcript variant X1
tRNA-histidine guanylyltransferase 1-like, transcript variant X2
probable tRNA(His) guanylyltransferase isoform X1
probable tRNA(His) guanylyltransferase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
ADAM metallopeptidase domain 19b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ADAM metallopeptidase domain 19b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 19 isoform X1
disintegrin and metalloproteinase domain-containing protein 19 isoform X2
ubiquitin-like domain containing CTD phosphatase 1
ubiquitin-like domain-containing CTD phosphatase 1
sodium-dependent phosphate transport protein 2A-like, transcript variant X4
sodium-dependent phosphate transport protein 2A-like, transcript variant X5
sodium-dependent phosphate transport protein 2A-like, transcript variant X6
sodium-dependent phosphate transport protein 2A-like, transcript variant X1
sodium-dependent phosphate transport protein 2A-like, transcript variant X3
sodium-dependent phosphate transport protein 2A-like, transcript variant X2
sodium-dependent phosphate transport protein 2A-like isoform X4
sodium-dependent phosphate transport protein 2A-like isoform X5
sodium-dependent phosphate transport protein 2A-like isoform X6
sodium-dependent phosphate transport protein 2A-like isoform X1
sodium-dependent phosphate transport protein 2A-like isoform X2
sodium-dependent phosphate transport protein 2A-like isoform X3
uncharacterized LOC122556948, transcript variant X2
uncharacterized LOC122556948, transcript variant X1
regulator of G-protein signaling 14-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
regulator of G-protein signaling 14-like, transcript variant X3
regulator of G-protein signaling 14-like, transcript variant X1
regulator of G-protein signaling 14-like isoform X2
regulator of G-protein signaling 14-like isoform X3
regulator of G-protein signaling 14-like isoform X1
uncharacterized LOC122556802, transcript variant X5
uncharacterized LOC122556802, transcript variant X1
uncharacterized LOC122556802, transcript variant X4
uncharacterized protein LOC122556802 isoform X1
uncharacterized LOC122556802, transcript variant X3
uncharacterized LOC122556802, transcript variant X2
uncharacterized protein LOC122556802 isoform X2
uncharacterized protein LOC122556802 isoform X3
uncharacterized LOC122556802, transcript variant X6
uncharacterized protein LOC122556802 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 107 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
myelin-associated glycoprotein-like, transcript variant X4
myelin-associated glycoprotein-like, transcript variant X5
myelin-associated glycoprotein-like, transcript variant X3
myelin-associated glycoprotein-like, transcript variant X1
myelin-associated glycoprotein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
myelin-associated glycoprotein-like isoform X3
myelin-associated glycoprotein-like isoform X4
myelin-associated glycoprotein-like isoform X1
sialoadhesin-like, transcript variant X1
sialoadhesin-like, transcript variant X2
dihydropyrimidinase-related protein 1-like, transcript variant X1
dihydropyrimidinase-related protein 1-like, transcript variant X2
dihydropyrimidinase-related protein 1-like
dihydropyrimidinase-related protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
janus kinase and microtubule interacting protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
janus kinase and microtubule-interacting protein 2 isoform X1
janus kinase and microtubule interacting protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
janus kinase and microtubule-interacting protein 2 isoform X2
uncharacterized LOC122556807, transcript variant X2
uncharacterized LOC122556807, transcript variant X1
synaptonemal complex central element protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
slit homolog 3 protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
slit homolog 3 protein-like, transcript variant X2
melanin-concentrating hormone receptor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
hepatitis A virus cellular receptor 1 homolog, transcript variant X2
hepatitis A virus cellular receptor 1 homolog, transcript variant X1
hepatitis A virus cellular receptor 1 homolog
family with sequence similarity 193 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
lateral signaling target protein 2 homolog, transcript variant X1
lateral signaling target protein 2 homolog isoform X1
lateral signaling target protein 2 homolog, transcript variant X2
lateral signaling target protein 2 homolog isoform X2
lateral signaling target protein 2 homolog, transcript variant X3
lateral signaling target protein 2 homolog isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
histone-lysine N-methyltransferase NSD2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
fibroblast growth factor receptor 4-like, transcript variant X2
fibroblast growth factor receptor 4-like, transcript variant X1
fibroblast growth factor receptor 4-like
uncharacterized protein in mobD 3'region-like
zinc finger protein 346-like, transcript variant X3
zinc finger protein 346-like, transcript variant X2
zinc finger protein 346-like, transcript variant X1
AT-rich interactive domain-containing protein 5B-like, transcript variant X1
AT-rich interactive domain-containing protein 5B-like, transcript variant X2
AT-rich interactive domain-containing protein 5B-like
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I), transcript variant X8
beta-1,4-galactosyltransferase 7 isoform X5
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I), transcript variant X5
beta-1,4-galactosyltransferase 7 isoform X2
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I), transcript variant X3
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I), transcript variant X2
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I), transcript variant X4
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
beta-1,4-galactosyltransferase 7 isoform X1
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I), transcript variant X7
beta-1,4-galactosyltransferase 7 isoform X4
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I), transcript variant X6
beta-1,4-galactosyltransferase 7 isoform X3
uncharacterized LOC122556955, transcript variant X2
uncharacterized LOC122556955, transcript variant X1
homeodomain-interacting protein kinase 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NEDD4-binding protein 3 homolog, transcript variant X3
NEDD4-binding protein 3 homolog, transcript variant X2
NEDD4-binding protein 3 homolog, transcript variant X6
NEDD4-binding protein 3 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
NEDD4-binding protein 3 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
NEDD4-binding protein 3 homolog, transcript variant X5
rab11 family-interacting protein 2-like, transcript variant X2
rab11 family-interacting protein 2-like, transcript variant X5
rab11 family-interacting protein 2-like, transcript variant X4
rab11 family-interacting protein 2-like, transcript variant X3
rab11 family-interacting protein 2-like, transcript variant X1
rab11 family-interacting protein 2-like isoform X1
rab11 family-interacting protein 2-like isoform X3
rab11 family-interacting protein 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
lysine-specific demethylase 3B-like, transcript variant X2
lysine-specific demethylase 3B-like, transcript variant X1
lysine-specific demethylase 3B-like isoform X2
lysine-specific demethylase 3B-like isoform X1
receptor expression-enhancing protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
receptor expression-enhancing protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
receptor expression-enhancing protein 2-like isoform X1
receptor expression-enhancing protein 2-like isoform X2
uncharacterized LOC122556834, transcript variant X1
uncharacterized LOC122556834, transcript variant X2
uncharacterized protein LOC122556834 isoform X1
uncharacterized LOC122556834, transcript variant X3
uncharacterized protein LOC122556834 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Ig gamma-2B chain C region-like, transcript variant X2
Ig gamma-2B chain C region-like isoform X2
immunoglobulin lambda-1 light chain-like, transcript variant X2
immunoglobulin lambda-1 light chain-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 714 Proteins
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
CDC23 (cell division cycle 23, yeast, homolog)
GDNF family receptor alpha-4-like, transcript variant X2
GDNF family receptor alpha-4-like, transcript variant X1
GDNF family receptor alpha-4-like isoform X2
GDNF family receptor alpha-4-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122556961, transcript variant X1
uncharacterized protein LOC122556961 isoform X1
uncharacterized LOC122556961, transcript variant X2
uncharacterized protein LOC122556961 isoform X2
protein FAM53A-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein FAM53A-like, transcript variant X1
protein FAM53A-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein FAM53A-like, transcript variant X2
protein FAM53A-like, transcript variant X3
protein FAM53A-like, transcript variant X4
C-terminal-binding protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
C-terminal-binding protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
C-terminal-binding protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
C-terminal-binding protein 1-like isoform X1
C-terminal-binding protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
C-terminal-binding protein 1-like isoform X2
C-terminal-binding protein 1-like isoform X3
transmembrane emp24 domain-containing protein 9-like
acid sphingomyelinase-like phosphodiesterase 3b
COORDINATES: nucleotide motif:Rfam:12.0:RF00090
fibroblast growth factor receptor-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tissue factor pathway inhibitor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tissue factor pathway inhibitor-like, transcript variant X1
GULP PTB domain containing engulfment adaptor 1a, transcript variant X2
GULP PTB domain containing engulfment adaptor 1a, transcript variant X5
GULP PTB domain containing engulfment adaptor 1a, transcript variant X4
GULP PTB domain containing engulfment adaptor 1a, transcript variant X1
GULP PTB domain containing engulfment adaptor 1a, transcript variant X3
GULP PTB domain containing engulfment adaptor 1a, transcript variant X8
GULP PTB domain containing engulfment adaptor 1a, transcript variant X6
GULP PTB domain containing engulfment adaptor 1a, transcript variant X7
PTB domain-containing engulfment adapter protein 1 isoform X1
PTB domain-containing engulfment adapter protein 1 isoform X2
collagen alpha-1(I) chain-like, transcript variant X1
collagen alpha-1(I) chain-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
collagen alpha-1(I) chain-like isoform X1
collagen alpha-1(I) chain-like isoform X3
collagen alpha-1(I) chain-like, transcript variant X2
collagen alpha-1(III) chain-like isoform X2
uncharacterized LOC122556850, transcript variant X1
uncharacterized LOC122556850, transcript variant X2